ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
Dow Jones
38.239,66
0,40%
Euro vs US Dollar
1,07005
0,00%
Bitcoin
63.041,10
-1,09%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Akero Therapeutics Inc (AKRO)

  7. Akero Therapeutics Inc (AKRO) News

AKRO Akero Therapeutics Inc

19,42
0,49 (2,59%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Akero Therapeutics Inc AKRO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,49 2,59% 19,42 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
19,18 18,95 19,97 19,74 18,93
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.3.202422:02GLOBEAkero Therapeutics Announces Closing of Public Offering of..
07.3.202422:01GLOBEAkero Therapeutics Announces Publication of Phase 2b..
07.3.202402:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202402:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202423:25EDGAR2Form 8-K - Current report
06.3.202423:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06.3.202403:13GLOBEAkero Therapeutics Announces Pricing of Public Offering of..
05.3.202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202412:05IHMARKETNEWSAMD Hits Regulatory Roadblock, GitLab’s Stock Tumbles on..
04.3.202423:34EDGAR2Form 144 - Report of proposed sale of securities
04.3.202423:30EDGAR2Form 144 - Report of proposed sale of securities
04.3.202423:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04.3.202422:21GLOBEAkero Therapeutics Announces Proposed Public Offering of..
04.3.202413:55EDGAR2Form 8-K - Current report
04.3.202412:00GLOBEAkero Therapeutics Reports Statistically Significant..
29.2.202422:42EDGAR2Form S-8 - Securities to be offered to employees in employee..
29.2.202414:00GLOBEAkero Therapeutics to Present Topline Week 96 Results from..
29.2.202413:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29.2.202413:15EDGAR2Form 8-K - Current report
29.2.202413:00GLOBEAkero Therapeutics Reports Fourth Quarter and Full Year 2023..
14.2.202403:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
03.1.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202414:15GLOBEAkero Therapeutics to Present at the 42nd Annual J.P. Morgan..
30.12.202302:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.12.202300:07EDGAR2Form 144 - Report of proposed sale of securities
19.12.202302:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202302:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202302:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202302:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202302:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202313:08EDGAR2Form 8-K - Current report
18.12.202313:00GLOBEAkero Therapeutics Announces First Patients Dosed in..
12.12.202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202322:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202303:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202302:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.12.202314:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202323:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202313:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202313:15EDGAR2Form 8-K - Current report
13.11.202313:00GLOBEAkero Therapeutics Reports Third Quarter 2023 Financial..
10.11.202314:57GLOBEAkero Therapeutics to Present Late-Breaking Oral and Poster..
08.11.202313:00GLOBEAkero Therapeutics to Present at Upcoming Healthcare..
17.10.202322:05GLOBEAkero Therapeutics to Present at the H.C. Wainwright 7th..
10.10.202314:04EDGAR2Form 8-K - Current report
10.10.202313:00GLOBEAkero Therapeutics Reports Encouraging 36-Week Analysis of..

Kürzlich von Ihnen besucht

NASDAQ
AKRO
Akero Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten